Výsledky vyhledávání - "Kokoviadou K"

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival (Annals of Hematology, (2018), 97, 9, (1671-1682), 10.1007/s00277-018-3361-2)

Autor: Katodritou, E. Kyrtsonis, M.-C. Delimpasi, S. Kyriakou, D. Symeonidis, A. Spanoudakis, E. Vasilopoulos, G. Anagnostopoulos, A. Kioumi, A. Zikos, P. Aktypi, A. Briasoulis, E. Megalakaki, A. Repousis, P. Adamopoulos, I. Gogos, D. Kotsopoulou, M. Pappa, V. Papadaki, E. Fotiou, D. Nikolaou, E. Giannopoulou, E. Hatzimichael, E. Giannakoulas, N. Douka, V. Kokoviadou, K. Timotheatou, D. Terpos, E.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::f33ef854dffeb283381ed05155066814
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107118

Zobrazit plný text záznamu

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies

Autor: Zagouri, F. Kastritis, E. Zomas, A. Terpos, E. Katodritou, E. Symeonidis, A. Delimpasi, S. Pouli, A. Vassilakopoulos, T.P. Michalis, E. Giannouli, S. Kartasis, Z. Christoforidou, A. Kokoviadou, K. Hatzimichael, E. Gika, D. Megalakaki, C. Papaioannou, M. Kyrtsonis, M.-C. Konstantopoulos, K. Dimopoulos, M.A. the Greek Myeloma Study Group

Objectives: To evaluate the prognostic impact of hypercalcemia in newly diagnosed patients with symptomatic multiple myeloma (MM), especially after the incorporation of new agents. Methods: we analyzed the outcomes of newly diagnosed patients with sy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::b9e952ddaec3c6130f0161dd6c295cfa
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126553

Zobrazit plný text záznamu

ESTIMATED GLOMERULAR FILTRATION (EGFR) CALCULATED BY CKD-EPI EQUATION COMBINED WITH THE INTERNATIONAL STAGING SYSTEM PROVIDES A POWERFUL PROGNOSTIC MODEL FOR EARLY MORTALITY IN MYELOMA PATIENTS

Autor: Katodritou, E Palaska, V Giannopoulou, E Papadaki, S Gerofotis, A Karampatzakis, N Keramidioti, K Verrou, E Kokoviadou, K Batsis, I others

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3da5df4aa165e7997b6b04d64e0c5b4c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2954566

Zobrazit plný text záznamu

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Autor: Katodritou, E. Terpos, E. Kastritis, E. Delimpasis, S. Symeonidis, A.S. Repousis, P. Kyrtsonis, M.-C. Vadikolia, C. Michalis, E. Polychronidou, G. Michael, M. Papadaki, S. Papathanasiou, M. Kokoviadou, K. Kioumi, A. Vlachaki, E. Hadjiaggelidou, C. Kouraklis, A. Patsias, I. Gavriatopoulou, M. Kotsopoulou, M. Verrou, E. Gastari, V. Christoulas, D. Giannopoulou, E. Pouli, A. Konstantinidou, P. Anagnostopoulos, A. Dimopoulos, M.-A.

Involvement of the central nervous system (CNS) is a rare complication of multiple myeloma (MM). Herein, we have described the incidence, characteristics, prognostic factors for post CNS-MM survival, and outcome of CNS-MM and explored the efficacy of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cdc5be753c1ee2a5093c8946278673ff
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3124842

Zobrazit plný text záznamu